← Open Payments lookup

EMILIJA ROSENTHAL: Open Payments

NPI 1710485479 · DALLAS, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$633 in 26 payments from 9 companies in 2025. Trend: 2023 $840 · 2024 $620 · 2025 $633

Food & beverage: $633
CompanyPaymentsAmount
Gilead Sciences, Inc.8$184
ViiV Healthcare Company5$138
Merck Sharp & Dohme LLC3$93
EMD Serono, Inc.3$92
Novo Nordisk Inc3$48
Theratechnologies Inc.1$23
Hologic Sales and Service, LLC1$20
TerSera Therapeutics LLC1$19
Salix Pharmaceuticals, a division of Bausch Health US, LLC1$14

Products named: PIFELTRO, RUKOBIA, CABENUVA, Ozempic, EGRIFTA, APTIMA, Quzyttir, APRETUDE.

Industry payments across TX — which companies pay providers there.